Drugs / GS-9876
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02885181 | Sep 2016 → Aug 2017 | rheumatoid arthritis | Gilead Sciences | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GS-9876 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02885181 ↗ |